In a filing, TELA Bio Inc revealed its 10% Owner EW HEALTHCARE PARTNERS FUND 2, acquired Company’s shares for reported $4.0 million on Nov 17 ’25. In the deal valued at $1.11 per share,3,604,000 shares were bought. As a result of this transaction, EW HEALTHCARE PARTNERS FUND 2, now holds 7,714,709 shares worth roughly $8.87 million.
Piper Sandler downgraded its TELA Bio Inc [TELA] rating to a Neutral from a an Overweight in a research note published on March 21, 2025; the price target was decreased to $2 from $5. A number of analysts have revised their coverage, including Lake Street’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. Piper Jaffray began covering TELA with “an Overweight” recommendation on December 03, 2019. JMP Securities started covering the stock on December 03, 2019. It rated TELA as “a Mkt outperform”.
Price Performance Review of TELA
On Friday, TELA Bio Inc [NASDAQ:TELA] saw its stock jump 2.68% to $1.15. Over the last five days, the stock has gained 8.49%. TELA Bio Inc shares have fallen nearly -60.88% since the year began. Nevertheless, the stocks have fallen -61.92% over the past one year. While a 52-week high of $3.20 was reached on 01/02/25, a 52-week low of $0.86 was recorded on 04/08/25.
Levels Of Support And Resistance For TELA Stock
The 24-hour chart illustrates a support level at 1.1267, which if violated will result in even more drops to 1.1033. On the upside, there is a resistance level at 1.1667. A further resistance level may holdings at 1.1833.
How much short interest is there in TELA Bio Inc?
A steep rise in short interest was recorded in TELA Bio Inc stocks on 2025-11-14, dropping by 7222.0 shares to a total of 0.42 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 0.42 million shares. There was a decline of -1.73%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 03, 2019 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating.
